Figure S1. Immunophenotyping analysis of AM-MSCs, UC-MSCs, and CP-MSCs. (PDF 489 kb
A Bright-field microscopy images of cultured UC-MSC in passage 3 (i) and AT-MSC in passage 24 (ii). ...
Additional file 1: Figure S1. Cell vitality assay of hAMSCs with PI3K-AKT-mTOR signal reactivation a...
Figure S2. Additional data on flow cytometry. (A) Expression of CD44, CD73, and CD90 in induced plur...
Table S3. GO term enriched by genes specifically expressed in CP-MSCs (partly). (PDF 439 kb
Primer sequences for Real Time PCR analysis and their respective product sizes. (DOCX 13 kb
Additional file 2. Figure S2: Comparation of the T cells after coculturing with or without hAMSCs pr...
Table S1. Antibodies used in this study Table S2. Primers used for semiquantitative and quantitative...
Identification of stem cells. (A–F) Flow cytometry analysis of immune-markers in human UC-MSCs. (G) ...
Figure S1. Additional data on cell morphology. Light micrographs showing the morphology of induced p...
Supplemental figures. Figure S1: Analysis of MSC phenotypic markers by flow cytometry. Figure S2: An...
A Viability of hMSC of all sources during a 7-day follow-up period during early passages (passages 3...
Additional file 5. The details accompanied with the main manuscript including Additional Figure Lege...
Gene list of exclusive groups and shared genes of AF-MSCs, HREpCs and UM51. (XLS 995Â kb
Figure S1. An antibody microarray to test the level of the growth factors derived from the hAMSCs. (...
Figure S1. (A) A flow chart of UC-MSC preparation for clinical use, including cell isolation, expans...
A Bright-field microscopy images of cultured UC-MSC in passage 3 (i) and AT-MSC in passage 24 (ii). ...
Additional file 1: Figure S1. Cell vitality assay of hAMSCs with PI3K-AKT-mTOR signal reactivation a...
Figure S2. Additional data on flow cytometry. (A) Expression of CD44, CD73, and CD90 in induced plur...
Table S3. GO term enriched by genes specifically expressed in CP-MSCs (partly). (PDF 439 kb
Primer sequences for Real Time PCR analysis and their respective product sizes. (DOCX 13 kb
Additional file 2. Figure S2: Comparation of the T cells after coculturing with or without hAMSCs pr...
Table S1. Antibodies used in this study Table S2. Primers used for semiquantitative and quantitative...
Identification of stem cells. (A–F) Flow cytometry analysis of immune-markers in human UC-MSCs. (G) ...
Figure S1. Additional data on cell morphology. Light micrographs showing the morphology of induced p...
Supplemental figures. Figure S1: Analysis of MSC phenotypic markers by flow cytometry. Figure S2: An...
A Viability of hMSC of all sources during a 7-day follow-up period during early passages (passages 3...
Additional file 5. The details accompanied with the main manuscript including Additional Figure Lege...
Gene list of exclusive groups and shared genes of AF-MSCs, HREpCs and UM51. (XLS 995Â kb
Figure S1. An antibody microarray to test the level of the growth factors derived from the hAMSCs. (...
Figure S1. (A) A flow chart of UC-MSC preparation for clinical use, including cell isolation, expans...
A Bright-field microscopy images of cultured UC-MSC in passage 3 (i) and AT-MSC in passage 24 (ii). ...
Additional file 1: Figure S1. Cell vitality assay of hAMSCs with PI3K-AKT-mTOR signal reactivation a...
Figure S2. Additional data on flow cytometry. (A) Expression of CD44, CD73, and CD90 in induced plur...
DOI
Add to ORKG